036: Molecular classification and subgrouping for personalized treatment of CNS malignancies

HIPO Investigator:

Prof. Pfister

Prof. von Deimling

Prof. Wick

Prof. Heorld-Mende

Dr. Debus

Dr. Witt

Supported by: NCT-POP

Entity: diverse brain tumors

Publications:

Korshunov A et al.; H3-/IDH-wild type pediatric glioblastoma is comprised of molecularly and prognostically distinct subtypes with associated oncogenic drivers; Acta Neuropathol 2017

International Cancer Genome Consortium PedBrain Tumor Project; Recurrent MET fusion genes represent a drug target in pediatric glioblastoma; Nature Medicine 2016

Thomas C et al.; Methylation profiling of choroid plexus tumors reveals 3 clinically distinct subgroups; Neuro Oncol 2016

Sahm F et al.; Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets, Acta Neuropathol. 2015

Sturm D et al.; New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs, Cell 2016

Hovestadt et al.; Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays; Acta Neuropathol 2013

 

DKFZ Logo 3zu Research en Black Blue sRGB

4c nctlogo 2009

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.